Close

Vitae Pharmaceuticals to Announce Second Quarter 2015 Financial Results on August 4, 2015

July 28, 2015 7:00 AM EDT

FORT WASHINGTON, Pa., July 28, 2015 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc. (NASDAQ: VTAE), a clinical-stage biotechnology company, will host a conference call on Tuesday, August 4, 2015 at 4:30 p.m. EDT to discuss second quarter 2015 financial results and recent operational highlights. A question-and-answer session will follow Vitae's remarks.

To participate on the live call, please dial 844-423-9893 (domestic) or +1-716-247-5808 (international) and provide the conference ID 94533069 five to 10 minutes before the start of the call.

A live audio webcast of the call will also be available via the "Investor Relations" page of the Vitae website, www.vitaepharma.com. Please log on through Vitae's website approximately 10 minutes before the scheduled start time. A replay of the webcast will be archived on Vitae's website for 90 days following the call.

About Vitae Pharmaceuticals

Vitae Pharmaceuticals is a clinical-stage biotechnology company focused on discovering and developing first-in-class, small molecule drugs for difficult-to-drug disease targets that can potentially address significant unmet medical needs, including disclosed programs in diabetes, Alzheimer's disease, autoimmune disorders, atopic dermatitis and acute coronary syndrome. This robust and growing portfolio of novel product candidates is generated internally by ContourĀ®, Vitae's proprietary structure-based drug discovery platform.

For additional information, please visit the company's website at www.vitaepharma.com.

CONTACT: INVESTORS:
         Vitae Pharmaceuticals, Inc.
         Richard S. Morris, CPA
         Chief Financial Officer
         (215) 461-2000
         [email protected]

         Westwicke Partners
         John Woolford
         (443) 213-0506
         [email protected]

         MEDIA:
         6 Degrees PR
         Tony Plohoros
         (908) 591-2839
         [email protected]

Source: Vitae Pharmaceuticals


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Press Releases

Related Entities

Earnings